Correlation Between Trustcash Holdings and Travere Therapeutics
Can any of the company-specific risk be diversified away by investing in both Trustcash Holdings and Travere Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Trustcash Holdings and Travere Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Trustcash Holdings and Travere Therapeutics, you can compare the effects of market volatilities on Trustcash Holdings and Travere Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Trustcash Holdings with a short position of Travere Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Trustcash Holdings and Travere Therapeutics.
Diversification Opportunities for Trustcash Holdings and Travere Therapeutics
-0.49 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Trustcash and Travere is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Trustcash Holdings and Travere Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Travere Therapeutics and Trustcash Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Trustcash Holdings are associated (or correlated) with Travere Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Travere Therapeutics has no effect on the direction of Trustcash Holdings i.e., Trustcash Holdings and Travere Therapeutics go up and down completely randomly.
Pair Corralation between Trustcash Holdings and Travere Therapeutics
Given the investment horizon of 90 days Trustcash Holdings is expected to under-perform the Travere Therapeutics. In addition to that, Trustcash Holdings is 6.27 times more volatile than Travere Therapeutics. It trades about -0.22 of its total potential returns per unit of risk. Travere Therapeutics is currently generating about 0.11 per unit of volatility. If you would invest 1,750 in Travere Therapeutics on September 1, 2024 and sell it today you would earn a total of 131.00 from holding Travere Therapeutics or generate 7.49% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 95.24% |
| Values | Daily Returns |
Trustcash Holdings vs. Travere Therapeutics
Performance |
| Timeline |
| Trustcash Holdings |
| Travere Therapeutics |
Trustcash Holdings and Travere Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Trustcash Holdings and Travere Therapeutics
The main advantage of trading using opposite Trustcash Holdings and Travere Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Trustcash Holdings position performs unexpectedly, Travere Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Travere Therapeutics will offset losses from the drop in Travere Therapeutics' long position.| Trustcash Holdings vs. Remote Dynamics | Trustcash Holdings vs. Wellstar International | Trustcash Holdings vs. Encounter Technologi | Trustcash Holdings vs. Health Sciences Gr |
| Travere Therapeutics vs. Tff Pharmaceuticals | Travere Therapeutics vs. Eliem Therapeutics | Travere Therapeutics vs. Inhibrx | Travere Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |